摘要 |
The present invention relates to a novel crystalline form of (2R)-(3-amino-2-fluoropropyl)phosphinic acid, the present invention is also directed to the use of the crystalline form for the treatment of gastrointestinal disorders as well as to a pharmaceutical compositions comprising the same and a process for the preparation of the crystalline form.
|